Trials

Our team of experienced researchers, nurses, study coordinators, and certified medical laboratory technicians create an environment of ethical and scientific standards that lead to our precision and reliable results.

With more than 400 trials completed since 1998, you can be assured that our conduct, quality control, recording, and reporting are done in a manner that protects the rights and safety of trial participants, while providing credible and accurate data.

As a consistent, and many times leading enroller, sponsors can rely on our recruitment efforts to provide the data that is needed, not only for entry, but for ongoing retention of records. Our patient care commitment is equally as strong as our commitment to data accuracy.

“A Multicenter, Randomized, Double-Blind, Four-Week, Bilateral Study of the Safety and Efficacy of Two Concentrations of Drug Ointment Administered Once or Twice a Day in Adolescents with Atopic Dermatitis.”

“A Phase III Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Re-treatment with Drug in Subjects with Moderate to Severe Plaque Psoriasis.”

“A Parallel-Group, Vehicle-Controlled, Randomized, Double-Blind Study of the Efficacy and Safety of Product Drug and Product Drug in Subjects with Seborrheic Dermatitis.”

“A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Drug to Drug and Placebo in Patients with Moderate to Severe Plaque Psoriasis with a Long-Term Extension Period.”

“A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic Drug Cream, 1% and Reference Listed Drug, 1% and Compare Both Active Treatments to a Vehicle Control in the Treatment of Interdigital Tinea Pedis.”

“A Phase II Study of Photodynamic Therapy with Drug Topical Solution verses Drug Enrolled 21 Topical Solution Vehicle-Blue Light Using Spot and Broad Area Application and Incubation times of 1,2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp.”

“A Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Subcutaneous Drug to Demonstrate Efficacy after Twelve Weeks of treatment, and to Assess the Safety, Tolerability and Long-Term Efficacy up to One Year in Subjects with Moderate to Severe Chronic Plaque-Type Psoriasis.”

“A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Safety and Efficacy of Drug Solution 0.03%, 0.1% and 0.3% Compared with Vehicle in Men with Androgenic Alopecia with an Open-Label Active Comparator Group.”

“A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Assess the Safety of Drug Gel Applied Topically Once Daily in Subjects with Moderate to Severe Facial Erythema Associated with Rosacea.”

“A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Drug Topical Solution vs. Solution Vehicle in the Treatment Onychomycosis of the Toenail in Adults.”

“A Multicenter, Randomized, Double-Blind, 12-Week Study of the Safety and Efficacy of Drug vs. Drug Vehicle in the Treatment of Patients with Mild-to-Moderate Plaque-Type Psoriasis.”

“A Randomized Study to Evaluate the Efficacy and Safety of Adding Topical Therapy to Drug in Subjects with Moderate to Severe Plaque Psoriasis.”

“Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Multinational, Parallel-Group Study of the Efficacy and Safety of Drug Ointment in Concentrations of 0.01, 0.03 and 0.1% over 4 Weeks in Patients with Atopic Dermatitis (AD).”

“A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Safety and Efficacy of Drug in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenails for 52 Weeks.”

“A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Drug vs. Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails.”

“A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Drug and Drug to Drug and Both Active Treatments to a Vehicle Control in the Treatment of Psoriasis Vulgaris.”

“A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Drug Administered Subungually or Distally in the Treatment of Distal Subungual or Distally in the Treatment of Distal Subungual Onychomycosis of the Toenail.”

“A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Drug in a Single Intravenous and a Single Subcutaneous Administration in Healthy Subjects and in Subjects with Moderate to Severe Psoriasis.”

“A 12 Month, Long-Term Follow-Up Study of Patients with Actinic Keratoses on the Head (Face or Scalp) Who Have Completed Day 57 in Studies A1 and A2.”